JP Patent

JP7455144B2 — トレプロスチニルプロドラッグの乾燥粉末組成物およびその使用方法

Assigned to Insmed Inc · Expires 2024-03-25 · 2y expired

What this patent protects

Patent listed against Remodulin.

Drugs covered by this patent

Remodulin (TREPROSTINIL) · United Therap

Patent Metadata

Patent number: JP7455144B2
Jurisdiction: JP
Classification: —
Expires: 2024-03-25
Drug substance claim: No
Drug product claim: No
Assignee: Insmed Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.